BroadSpot Imaging

San Francisco, United States Founded: 2013 • Age: 13 yrs
Ophthalmological imaging devices for anterior as well as posterior regions

About BroadSpot Imaging

BroadSpot Imaging is a Healthcare company based in San Francisco (United States) founded in 2013 by Tushar Ranchod. It operates as an ophthalmological imaging devices for anterior as well as posterior regions. BroadSpot Imaging has raised $8 million across 3 funding rounds from investors including Phoenix Venture Partners, Camino Real Capital Partners and BlueStone Venture Partners. The company has 8 employees. Its chief executive is Randy Krall. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging. Its legal entity is BROADSPOT IMAGING CORPORATION. Its competitors include PlenOptika, machineMD, ArcScan, EyeNetra and Smart Vision Labs and 3 more; 7 of its 8 listed competitors have raised funding.

Company details

BroadSpot Imaging was founded in 2013 in San Francisco, United States, and operates in the ophthalmological imaging sector. Products are developed by combining advanced computational optics with consumer electronics to create low-cost, portable cameras for anterior and posterior eye segments. Two device familiesportable and widefieldare based on a common platform integrated with cloud-based services to support clinical care processes.

  • Headquarters San Francisco, United States
  • Employees 8
  • Founders Tushar Ranchod
  • Sectors
    Healthcare
  • Website broadspotimaging.com
  • Legal Name Broadspot Imaging Corporation
Operational Areas
Key Metrics

Funding Insights of BroadSpot Imaging

BroadSpot Imaging has successfully raised a total of $8M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8M
  • Total Rounds 3
  • First Round $500,000

    (Sep 2016)

  • Investors Count 3

All 3 funding rounds of BroadSpot Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2018–Series A–Phoenix Venture Partners
Oct 2017$7.5MSeries A–Phoenix Venture Partners
Sep 2016$500,000Seed––
–
Valuation history

3 investors in total: 3 institutional.

Investors in BroadSpot Imaging

BroadSpot Imaging has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Phoenix Venture Partners, Camino Real Capital Partners and BlueStone Venture Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital firm funding transformative technologies
–phoenix-vp.comSan Mateo, United States
A private investment firm based in Santa Fe, New Mexico, focused on innovators and emerging technologies.
–caminorealcap.comSanta Fe, United States
-
–bluestonevp.com-
Premium access

Investor details for BroadSpot Imaging

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BroadSpot Imaging

2 people are tracked at BroadSpot Imaging (2 in leadership); the tracked headcount is 8.

NameRoleGroup
Tushar Ranchod
FounderLeadership
Randy Krall
CEOLeadership
Premium access

Complete people profiles for BroadSpot Imaging

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BroadSpot Imaging

3 dated milestones of BroadSpot Imaging across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded BroadSpot Imaging is founded.
  2. Funding First funding round of $500K.
  3. Funding Latest funding round, Series A,.

Competitors of BroadSpot Imaging

BroadSpot Imaging has 8 listed competitors in our database, 7 of them funded. They include PlenOptika, machineMD, ArcScan, EyeNetra and Smart Vision Labs, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
plenoptika.com2014Cambridge, United States$50,383–
Developer of a medical devices for measuring refractive errors
machinemd.com2019Bern, Switzerland$4.77M–
Diagnostic device for brain diseases is developed by machineMD.
arcscan.com2007Golden, United States$15.21M18
Ultrasound device for micron-resolution anterior chamber imaging is provided.
eyenetra.com2011Somerville, United States$7M3
Refractive errors are measured using smartphone camera attachments.
smartvisionlabs.com2013New York, United States$6.1M–
Refractive errors are tested via smartphone attachment by healthcare professionals.
oculus.de1895Frankfurt Am Main, Germany––
Eye diagnostic equipment is developed for ophthalmological applications.
glakolens.com2017Istanbul, Turkey$520,177–
Developer of non-invasive diagnostic to monitor intraocular pressure in glaucoma
alfaleus.in2018Hyderabad, India$58,568–
A portable VR-based device for visual field testing is offered.
Premium access

Detailed competitors of BroadSpot Imaging

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Ophthalmology

10 companies that operate in the same segment as BroadSpot Imaging (Ophthalmology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 9.64 B25,600
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M–100
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
2003Alpharetta, Georgia, United StatesUSD 66.8 MUSD 80.75 M79
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
2009Bengaluru, Karnataka, IndiaUSD 25.01 MUSD 4.85 M135
Gene therapies for ocular and neurodegenerative diseases are developed.
2015New York, New York, United States–USD 81.39 M381
Small molecule therapeutics for ophthalmic disorders are developed.
1987Watertown, United States–USD 31.37 M165
Therapies for metabolic and orphan diseases are developed by Rezolute.
2012Denver, Colorado, United States––59
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
2010Bengaluru, Karnataka, IndiaUSD 18.12 MUSD 4.78 M145
Therapeutics for retinal diseases are developed by the company.
2009Palo Alto, California, United StatesUSD 35.84 M–109
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Broadspot Imaging

Premium access

Complete news archive for BroadSpot Imaging

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BroadSpot Imaging

BroadSpot Imaging was founded in 2013 and raised its 1st funding round 3 years after it was founded.

BroadSpot Imaging is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Randy Krall is the current CEO of BroadSpot Imaging.

BroadSpot Imaging is a funded company, having raised a total of $8M across 3 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Sep 2016.

BroadSpot Imaging has 8 employees.

BroadSpot Imaging was founded in 2013 in San Francisco, United States, and operates in the ophthalmological imaging sector. Products are developed by combining advanced computational optics with consumer electronics to create low-cost, portable cameras for anterior and posterior eye segments. Two device familiesportable and widefieldare based on a common platform integrated with cloud-based services to support clinical care processes.

BroadSpot Imaging's top competitors include machineMD, EyeNetra and Smart Vision Labs.

BroadSpot Imaging has 3 investors. Key investors include Phoenix Venture Partners, Camino Real Capital Partners, and BlueStone Venture Partners.

BroadSpot Imaging operates through Broadspot Imaging Corporation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available